Low Alkaline Phosphatase in Celiac Disease
Yes, low alkaline phosphatase is commonly seen in celiac disease, particularly intestinal alkaline phosphatase (iAP), which is significantly reduced in the duodenal mucosa of patients with active disease and correlates with the severity of villous atrophy.
Understanding the Alkaline Phosphatase Abnormality
The reduction in alkaline phosphatase in celiac disease is specific to the intestinal isoenzyme, not the bone or liver isoenzymes typically measured in routine serum testing. This is a critical distinction that affects clinical interpretation:
Intestinal Alkaline Phosphatase (iAP)
- Mucosal expression is markedly decreased in newly diagnosed celiac disease patients, with reductions of approximately 76-80% compared to healthy controls 1, 2, 3
- The enzyme activity correlates directly with the degree of histological damage: patients with total villous atrophy show lower activity (mean 5.3 U/g) than those with partial villous atrophy (mean 14.3 U/g) 2
- Brush border enzyme activities including lactase, sucrase, and alkaline phosphatase all decrease with increasing mucosal damage 1, 4
Clinical Significance
The decreased iAP has functional consequences beyond just being a marker:
- iAP plays a crucial role in detoxifying lipopolysaccharide (LPS), the ligand for Toll-like receptor 4 (TLR4) 3
- Reduced iAP impairs intestinal barrier integrity, potentially contributing to the pathophysiology of celiac disease 5, 3
- The enzyme colocalizes with TLR4 at the epithelial surface, and its deficiency may enhance inflammatory processes 3
Response to Treatment
Alkaline phosphatase activity improves but may not fully normalize with gluten-free diet:
- iAP protein expression normalizes in children on a gluten-free diet 3
- However, in adults, alkaline phosphatase activity often remains depressed even after histological recovery, particularly in patients where lactase activity also fails to improve 4
- Approximately 13% of patients under 18 years and 33% of those over 18 years maintain low lactase activity despite treatment, with alkaline phosphatase showing similar patterns 4
Important Clinical Caveats
Serum vs. Tissue Measurements
Standard serum alkaline phosphatase testing is NOT useful for celiac disease diagnosis or monitoring 6. The guideline on liver disease explicitly states that bone alkaline phosphatase "is less useful in chronic liver disease as it is difficult to measure accurately in the presence of high values of liver alkaline phosphatase" 6, and this principle extends to gastrointestinal diseases where the intestinal isoenzyme is the relevant marker.
What Guidelines Actually Recommend
The American Gastroenterological Association guidelines on celiac disease 7 focus on:
- Serological abnormalities that correlate with bone disease (a separate concern): elevated PTH, elevated 1,25(OH)2-vitamin D, and diminished 25-OHD 7
- These relate to the osteoporosis complications of celiac disease (28% prevalence at spine, 15% at hip in newly diagnosed patients) 7, not to alkaline phosphatase as a diagnostic marker
Practical Implications
- Do not rely on routine serum alkaline phosphatase to screen for or monitor celiac disease
- The decreased intestinal alkaline phosphatase is primarily a research finding measured in duodenal biopsy tissue, not a clinically available test 1, 4, 2, 3
- Focus instead on tissue transglutaminase (tTG) antibodies for diagnosis and monitoring, as recommended by current guidelines 8, 9
Bottom Line for Clinical Practice
While intestinal alkaline phosphatase is indeed reduced in celiac disease and correlates with disease severity, this is not a clinically actionable finding in routine practice. The reduction occurs at the tissue level in duodenal mucosa and requires specialized measurement techniques not available in standard laboratory testing. Standard serum alkaline phosphatase measurements reflect bone and liver isoenzymes and are not useful for celiac disease diagnosis or monitoring.